Table 2.
Integrin α2 and Integrin β1 expression with clinicopathological variables in 50 NSCLC samples
| n | Integrin α2 | P | Integrin β1 | P | ||
|---|---|---|---|---|---|---|
| Age (years) | ≥60 | 29 | 28 | 0.577b | 9 | 0.233a |
| <60 | 21 | 21 | 10 | |||
| Gender | Male | 33 | 33 | 0.340b | 12 | 0.740a |
| Female | 17 | 16 | 7 | |||
| Histological Grade | Well-differentiate | 3 | 2 | 0.060b | 1 | 1.000b |
| Moderately-differentiate | 27 | 27 | 10 | |||
| Poor-differentiate | 20 | 20 | 8 | |||
| Stage | 0 | 1 | 0 | 0.020b | 0 | 0.799b |
| I | 23 | 23 | 8 | |||
| II | 22 | 22 | 10 | |||
| III | 4 | 4 | 1 |
aContinuity correction Chi-square
bFisher’s Exact Test